Sponsored Links
Main Menu
Treatment
Self Tests
OCD
- Facts about OCD
- OCD Questions & Answers
- YBOCS: Yale-Brown OCD Scale
- Sexual Obsessions
- Hoarding & Saving OCD
- Washing & Cleaning
- Homosexuality Anxiety
- Christians & OCD
- Medication for OCD
- Combining Medication for OCD
- CBT Therapy for OCD
- Therapy for Kids with OCD
- OCD & African Americans
- Herbal Remedies for OCD
- Brain Surgery for OCD
- Treatment Resistant OCD
- OCD & Depression
- Real People's OCD Stories
- Online Therapy for OCD
Spectrum Disorders
- Obsessive-Compulsive Disorder
- Tourette Syndrome
- Hypochondria
- Body Dysmorphic Disorder
- Depersonalization Disorder
- Trichotillomania (Hair Pulling)
- Compulsive Skin Picking
- Nail Biting
- Deliberate Self-Harm
- Olfactory Reference Syndrome
- Sexual Compulsions
- Compulsive Gambling
- Kleptomania
- Eating Disorders
- Obsessive Compulsive Personality
- Autistic Disorder
Anxiety & Mood
- Panic Disorder
- Panic Attacks
- Social Anxiety & Phobia
- Taijin Kyofusho
- Specific Phobias
- Generalized Anxiety
- Traumatic Stress Disorders
- Major Depressive Disorder
- Bipolar Disorder
- OCD & Bipolar
- Depression & God
Eating Disorders and Body Image
Possible new drug to treat early Alzheimer's
There’s a possible treatment for Alzheimer’s on the distant horizon. A new drug, gantenerumab, being developed has removed amyloid plaques from the grains of Alzheimer’s disease patients. It’s a small study and very early in the process, but early indicators are good that there is something here which can be developed. Data has been published in Archives of Neurology by Roche Holding AG, the Swiss drug maker.
It is believed that amyloid plaque building up on the brain cause Alzheimer’s and robs those people of the ability to remember. In truth, the mechanism behind Alzheimer’s has yet to be proved and is largely speculation. It is still a difficult disease to diagnose with certainty.
Now that they have discovered gantenerumab reduces the amyloid plaque, the question is whether that will translate into clinical benefit for the patients. They need to determine if gantenerumab is safe to use and what dose levels it is most effective. Since the drug binds to and removes amyloid plaque, it is believed to be a candidate for first line treatment of early Alzheimer’s. Ideally, it would slow the progression of the disease.
“These results and especially the rapidity of the effects observed on amyloid removal are very encouraging and pave the way for the development of a novel treatment for Alzheimer’s disease,” said Luca Santarelli, head of Roche’s global neuroscience disease division. “We know amyloid accumulates for 15 years before dementia, so why should you wait to remove it?”
About 25 million people worldwide suffer from Alzheimer’s. By 2030 that number will likely increase to 63 million and by 2050 it could reach as high as 114 million.
Source: MedScape, Huffington Post
OCD Self Test
Do you or a loved one feel like you might have a problem with OCD?
Take the Self Test now to get more information.
Sponsored Links
The information provided on brainphysics.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of brainphysics.com nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Click here to read our complete Terms of Use.
(877) 331-9311
Sponsored Links
You May Also Want To Read
Other People Are Also Reading
Online Support Groups
SupportGroups.com provides a support network for those facing life's challenges. Click on the following links to get a helping hand in a confidential, caring environment.